Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Newmark : Exclusively Represents Alexandria in $364 Million Partial Interest Sale of 400 Dexter – a Trophy Life Science Asset in Seattle, WA

09/22/2021 | 04:52am EDT
Newmark Exclusively Represents Alexandria in $364 Million Partial Interest Sale of 400 Dexter - a Trophy Life Science Asset in Seattle, WA September 21st, 2021 3:48pm
Contact Us
Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Saint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Cook Islands Costa Rica Croatia Cuba Curacao Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Republic of the Congo Reunion Romania Russia Rwanda Saint Barthelemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu U.S. Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe
Email Address is required

I would like to receive the latest updates from Newmark

By submitting your data through this form, you confirm that you are above the age of 18, that you have read and understood the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Newmark & Company Real Estate, Inc. in accordance with said policy.*
Thank you for sharing your information with Newmark!

September 21, 2021 12:00 PM

Newmark announces that it has arranged the off-market, partial interest sale of 400 Dexter - a trophy life science asset located in Seattle's South Lake Union for an implied gross valuation of $364 million or $1,255 per rentable square foot (RSF). The partial interest sale of 400 Dexter represents the second highest price per square foot paid for a life science asset in Seattle's history[1].

Newmark Co-Head of U.S. Capital MarketsKevin Shannon, Executive Managing Directors Ken White and Rob Hannan, Vice Chairman Nick Kucha, Senior Managing Director Michael Moll and Director Rachel Jones, in conjunction with local leasing team, Executive Managing Directors Jesse Ottele and Senior Managing Director Cavan O'Keefe represented the seller, an affiliate of Alexandria Real Estate Equities, Inc., a preeminent national owner, operator and developer of life science real estate. The buyer, Clarion Partners, has acquired a 70 percent interest in the property.

"This transaction marks another strong data point reflective of the current demand for core life science product in Seattle," said Shannon. "Life science fundamentals are faring better than the overall office fundamentals with rents that are now ranging from $65 to $80 NNN annually, which allowed us to achieve record setting pricing for the Puget Sound marketplace."

Ottele added, "The Puget Sound ranks third nationally for life science growth over the past five years with venture capital having increased 200 percent during that time frame. Seattle is the #1 city in the country for STEM jobs."

400 Dexter encompasses 290,111 RSF of first-class office and laboratory space in Seattle's South Lake Union. The Property, which is 100% leased, is anchored by Bristol Myers Squibb, and also home to Alexandria and The Collective, a hip urban social club concept that offers members exclusive access to fitness facilities, restaurant, event space and wellness programs.

One driving force behind Seattle's recent success has been its emergence as a national life science hub, which can be attributed to the combination of research, NIH funding, strong employment growth, educational opportunities and depth of skilled labor pool. Life Science venture capital funding in the Puget Sound hit $1.1B in Q1 2021, up 300% year over year.

The life science market in Seattle, which is concentrated in the Lake Union submarket and measures roughly six million square feet of inventory, has exceeded the performance of the overall market by a wide margin. Overall vacancy among Seattle life science buildings was less than 4 percent in the second quarter, and new inventory is virtually impossible to find, putting strong upward pressure on asking rents, according to Newmark Research. Seattle has ranked among the strongest real estate markets in the country in recent years.

[1] Newmark Research

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Our comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, growing startups to leading companies. In 2020, Newmark generated revenues in excess of $1.9 billion. Newmark, together with London-based partner Knight Frank and independently owned licensees, operates globally from approximately 490 offices with 19,300 professionals. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company's business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.


Newmark Group Inc. published this content on 21 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 September 2021 08:51:03 UTC.

© Publicnow 2021
All news about NEWMARK GROUP, INC.
10/22NEWMARK GROUP, INC. : Other Events (form 8-K)
10/21NEWMARK : Completes $43.5 Million Sale of 176 Federal Street in Boston, Massachusetts
10/21NEWMARK : Completes Sale of Multifamily Community in Tempe, Arizona for $45 Million
10/19NEWMARK GROUP, INC. : Other Events (form 8-K)
10/18NEWMARK : Elevates Sean Moynihan to Southeast Market Leader
10/18NEWMARK : Hires Mike Smith as Northwest Market Leader
10/15NEWMARK : Completes Sale of Life Sciences Redevelopment Opportunity in San Diego, Californ..
10/13NEWMARK : SB Real Estate Partners Acquires Multifamily Community in Mesa, Arizona for $24...
10/13NEWMARK : Expands International Capital Markets Group
10/13Newmark Group, Inc. Announces Executive Appointments
More news
Analyst Recommendations on NEWMARK GROUP, INC.
More recommendations
Financials (USD)
Sales 2021 2 566 M - -
Net income 2021 623 M - -
Net Debt 2021 - - -
P/E ratio 2021 5,75x
Yield 2021 0,27%
Capitalization 2 934 M 2 934 M -
Capi. / Sales 2021 1,14x
Capi. / Sales 2022 1,03x
Nbr of Employees 4 100
Free-Float 79,1%
Duration : Period :
Newmark Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEWMARK GROUP, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 15,00 $
Average target price 16,80 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Barry M. Gosin Chief Executive Officer
James D. Kuhn President & Head-Investor Services
Michael J. Rispoli Chief Financial Officer
Howard William Lutnick Chairman
Sridhar Potineni Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
NEWMARK GROUP, INC.105.76%2 934
CBRE GROUP, INC.65.69%34 195
KE HOLDINGS INC.-59.41%29 749
ZILLOW GROUP, INC.-31.09%23 480